Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|27|3531-3543

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.27, 2005-10, pp. : 3531-3543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Strategies for Immune-Mediated Anti-Viral Drug and Vaccine Development

By  

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1391-1401

Bentham Science Publishers

Access to resources Recommend Favorite

Computer Aided Drug Design Approaches to Develop Cyclooxygenase Based Novel Anti-Inflammatory and Anti-Cancer Drugs

By  

Current Pharmaceutical Design, Vol. 13, Iss. 34, 2007-12 ,pp. : 3505-3517

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer

By  

Current Bioactive Compounds, Vol. 3, Iss. 4, 2007-12 ,pp. : 295-301

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer

By  

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 317-329

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Marine-Derived Anti-Cancer Agents

By  

Current Pharmaceutical Design, Vol. 13, Iss. 33, 2007-01 ,pp. : 3417-3426

Bentham Science Publishers

Access to resources Recommend Favorite